Associations between HPV vaccination among women and their 11–14-year-old children

References

• Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR: Morb Mort Wkly Rep. 2010;59:630–32.
   PubMedGoogle Scholar
• Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of hpv types in cancers: implications for current and 9-valent HPV vaccines. JNCI: J Natl Cancer Inst. 2015;107(6):12. doi:10.1093/jnci/djv086.
   Web of Science ®Google Scholar
• Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. MMWR: Morb Mort Wkly Rep. 2016;65:1405–08.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years - United States, 2017. MMWR: Morb Mort Wkly Rep. 2018;67(33):909–17.
   PubMed Web of Science ®Google Scholar
• Thompson EL, Vamos CA, Piepenbrink R, Kadono M, Vázquez-Otero C, Matthes S, Daley EM. Human papillomavirus risk perceptions and relationship status: a barrier to HPV vaccination? J Behav Med. 2019. doi:10.1007/s10865-019-00025-4.
   PubMed Web of Science ®Google Scholar
• Henry J. Kaiser Foundation. Balancing on shaky ground: women, work and family health. Accessed May 2, 2019. https://www.kff.org/womens-health-policy/issue-brief/data-note-balancing-on-shaky-ground-women-work-and-family-health/.
   Google Scholar
• McRee AL, Reiter PL, Brewer NT. Vaccinating adolescent girls against human papillomavirus-who decides? Prev Med. 2010;50(4):213–14. doi:10.1016/j.ypmed.2010.02.001.
   PubMed Web of Science ®Google Scholar
• Damnjanovic K, Graeber J, Ilic S, Lam WY, Lep Ž, Morales S, Pulkkinen T, Vingerhoets L. Parental decision-making on childhood vaccination. Front Psychol. 2018;9:735. doi:10.3389/fpsyg.2018.00735.
   PubMed Web of Science ®Google Scholar
• Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi:10.1001/jamapediatrics.2013.2752.
   PubMed Web of Science ®Google Scholar
• Daley EM, Vamos CA, Thompson EL, Zimet GD, Rosberger Z, Merrell L, Kline NS. The feminization of HPV: how science, politics, economics and gender norms shaped US HPV vaccine implementation. Papillomavirus Res. 2017;3:142–48. doi:10.1016/j.pvr.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Rothman SM, Rothman DJ. Marketing hpv vaccine: implications for adolescent health and medical professionalism. Jama. 2009;302(7):781–86. doi:10.1001/jama.2009.1179.
   PubMed Web of Science ®Google Scholar
• Feemster KA, Winters SE, Fiks AG, Kinsman S, Kahn JA. Pediatricians’ intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing. J Adolesc Health. 2008;43(4):408–11. doi:10.1016/j.jadohealth.2008.06.012.
   PubMed Web of Science ®Google Scholar
• Rogers EM. Diffusion of innovations. 5th ed. New York (NY): Free Press; 2003.
   Google Scholar
• Sanson-Fisher RW. Diffusion of innovation theory for clinical change. Med J Aust. 2004;180:S55–56.
   PubMed Web of Science ®Google Scholar
• President’s Cancer Panel. HPV vaccination for cancer prevention: progress, opportunities, and a renewed call to action. A report to the president of the United States from the chair of the president’s cancer panel. Bethesda (MD): National Cancer Institute; 2018.
   Google Scholar
• Garland SM, Giuliano A, Brotherton J, Moscicki AB, Stanley M, Kaufmann AM, Bhatla N, Sankaranarayanan R, Palefsky JM, de Sanjose S. IPVS statement moving towards elimination of cervical cancer as a public health problem. Papillomavirus Res. 2018;5:87–88. doi:10.1016/j.pvr.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34(9):1187–92. doi:10.1016/j.vaccine.2016.01.023.
   PubMed Web of Science ®Google Scholar
• Dempsey AF, O’Leary ST. Human papillomavirus vaccination: narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Acad Pediatr. 2018;18(2S):S23–S27. doi:10.1016/j.acap.2017.09.001.
   PubMed Web of Science ®Google Scholar
• Kornides ML, Fontenot HB, McRee AL, Panozzo CA, Gilkey MB. Associations between parents’ satisfaction with provider communication and HPV vaccination behaviors. Vaccine. 2018;36(19):2637–42. doi:10.1016/j.vaccine.2018.03.060.
   PubMed Web of Science ®Google Scholar
• Kornides ML, McRee A-L, Gilkey MB. Parents who decline HPV vaccination: who later accepts and why? Acad Pediatr. 2018;18(2):S37–S43. doi:10.1016/j.acap.2017.06.008.
   PubMed Web of Science ®Google Scholar
• Casillas A, Singhal R, Tsui J, Glenn BA, Bastani R, Mangione CM. The impact of social communication on perceived HPV vaccine effectiveness in a low-income, minority population. Ethn Dis. 2011;21:495–501.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, McRee AL. Provider communication about HPV vaccination: A systematic review. Hum Vaccin Immunother. 2016;12(6):1454–68. doi:10.1080/21645515.2015.1129090.
   PubMed Web of Science ®Google Scholar
• Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer. A Report to the President of the United States from the President’s Cancer Panel. Bethesda (MD): National Cancer Institute; 2014.
   Google Scholar
• Kornides ML, Garrell JM, Gilkey MB. Content of web-based continuing medical education about HPV vaccination. Vaccine. 2017. doi:10.1016/j.vaccine.2017.07.038.
   Web of Science ®Google Scholar
• Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136(12):2752–60. doi:10.1002/ijc.29082.
   PubMed Web of Science ®Google Scholar
• Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JE. Racial differences in attitudes toward innovative medical technology. J Gen Intern Med. 2006;21(6):559–63. doi:10.1111/j.1525-1497.2006.00453.x.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Reiter PL, Magnus BE, McRee AL, Dempsey AF, Brewer NT. Validation of the vaccination confidence scale: a brief measure to identify parents at risk for refusing adolescent vaccines. Acad Pediatr. 2016;16(1):42–49. doi:10.1016/j.acap.2015.06.007.
   PubMed Web of Science ®Google Scholar
• Mohammed KA, Vivian E, Loux TM, Arnold LD. Factors associated with parents’ intent to vaccinate adolescents for human papillomavirus: findings from the 2014 national immunization survey-teen. Prev Chronic Dis. 2017;14. doi:10.5888/pcd14.160314.
   PubMed Web of Science ®Google Scholar
• Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008–2009. Pediatrics. 2011;128(5):830–39. doi:10.1542/peds.2011-0950.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Moss JL, McRee AL, Brewer NT. Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine. 2012;30(41):5928–34. doi:10.1016/j.vaccine.2012.07.045.
   PubMed Web of Science ®Google Scholar
• Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69(3):475–80. doi:10.1016/j.socscimed.2009.05.024.
   PubMed Web of Science ®Google Scholar